CN107334991A - 一种治疗鼻炎的中药及制备方法 - Google Patents
一种治疗鼻炎的中药及制备方法 Download PDFInfo
- Publication number
- CN107334991A CN107334991A CN201710713105.5A CN201710713105A CN107334991A CN 107334991 A CN107334991 A CN 107334991A CN 201710713105 A CN201710713105 A CN 201710713105A CN 107334991 A CN107334991 A CN 107334991A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- stemona
- vaseline
- kuh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 241001671204 Stemona Species 0.000 claims abstract description 21
- 241000218691 Cupressaceae Species 0.000 claims abstract description 20
- 241000427250 Moehringia Species 0.000 claims abstract description 20
- 235000009421 Myristica fragrans Nutrition 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229940099259 vaseline Drugs 0.000 claims abstract description 19
- 241001251949 Xanthium sibiricum Species 0.000 claims abstract description 18
- 239000012530 fluid Substances 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 16
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 15
- 244000235603 Acacia catechu Species 0.000 claims abstract description 15
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 15
- 239000001702 nutmeg Substances 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940116229 borneol Drugs 0.000 claims abstract description 14
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 14
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000000855 fermentation Methods 0.000 claims abstract description 9
- 230000004151 fermentation Effects 0.000 claims abstract description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 8
- 230000004913 activation Effects 0.000 claims abstract description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 8
- 150000003384 small molecules Chemical class 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000005119 centrifugation Methods 0.000 claims abstract description 6
- 244000270834 Myristica fragrans Species 0.000 claims abstract description 5
- 241000498779 Myristica Species 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 10
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 7
- 241000218394 Magnolia liliiflora Species 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 claims description 5
- 150000001637 borneol derivatives Chemical class 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 4
- 240000001949 Taraxacum officinale Species 0.000 claims description 2
- 210000005069 ears Anatomy 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical group [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 claims 1
- 206010067484 Adverse reaction Diseases 0.000 abstract description 8
- 230000006838 adverse reaction Effects 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 8
- 238000000746 purification Methods 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 2
- 206010011224 Cough Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 241000245665 Taraxacum Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000005187 foaming Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000036071 Rhinorrhea Diseases 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028140 Mucous stools Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000904014 Pappus Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 208000013228 adenopathy Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药制剂领域,公开了一种治疗鼻炎的中药及制备方法,其技术要点是:包括苦参、百部、冰片、儿茶、鹅不食、苍耳子、黄柏、凡士林和肉豆蔻,将苦参、百部、儿茶、鹅不食和苍耳子干燥、粉碎磨成细粉、过筛,制得组合粉末;将冰片、黄柏、凡士林和肉豆蔻加水煎煮、过滤、浓缩浸膏,制得膏状物;将组合粉末与膏状物混合均匀制得混合物,混合物再与活化的酵母液混合发酵,制得发酵液;将制得的发酵液中加入乙醇,静置,离心,小分子化,通过干燥,进行提纯,解决了现有治疗鼻炎的药物通过改变身体中的激素含量而缓解鼻炎症状,无法达到治愈鼻炎,而常规中药配方未经发酵提纯处理与患者皮肤接触后已发生皮肤红肿,气泡等不良反应的问题。
Description
技术领域
本发明涉及中药制剂领域,具体的讲是一种治疗鼻炎的中药及制备方法。
背景技术
鼻炎是临床常见病,多发病。主要表现为鼻塞、流鼻涕、头痛、头晕、嗅觉减退、注意力不集中、记忆力下降等症状,严重影响患者学习工作和生活。特别是近年来环境污染越来越严重,变化无常的天气致使鼻炎患者越来越多且趋向低龄化。鼻炎看似小病,实则危害极大,长期得不到有效治疗,还会诱发很多严重疾病,甚至危及生命。鼻炎是多种致病因素引起的(包括局部致病菌感染,机体变态反应性增高,微循环障碍,口鼻道复合体畸形及全身免疫力低下等),导致鼻粘膜水肿,增厚及息肉样囊性改变或纤维组织增生、血管阻塞、腺体萎缩。
目前治疗过敏性鼻炎的常有药物有减充血剂、皮质激素类、肥大细胞稳定剂、抗胆碱药、抗组胺药、白三烯受体拮抗剂等,但这些药物的使用或多或少都有一定的局限性,虽然能缓解发病时鼻炎的症状,但是无法完全治愈,随着冷空气或者抗原的产生,鼻炎依旧会复发。
以“就近处邪”、“治内以调外”为特色的中医外治疗法,对该病有显著而持久的疗效,常用外敷贴膏来治疗或减轻症状,但易使患者接触部位发生皮肤红肿、起泡等不良反应。
因此,需要一种能够辨证求因、审因施治、进行整体调节和系统治疗,并且通过对中药发酵、提纯、小分子化处理,使之药性温和,不易对患者皮肤造成红肿、起泡等不良反应的一种治疗鼻炎的中药及制备方法。
发明内容
本发明针对现有治疗鼻炎的药物通过改变身体中的激素含量而缓解鼻炎症状,无法达到治愈鼻炎,而常规中药配方未经发酵提纯处理与患者皮肤接触后已发生皮肤红肿,气泡等不良反应的问题,提供一种治疗鼻炎的中药及制备方法。
本发明解决上述技术问题,采用的技术方案是,一种治疗鼻炎的中药包括苦参、百部、冰片、儿茶、鹅不食、苍耳子、黄柏、凡士林和肉豆蔻。
进一步的,以重量份计,苦参5~20份、百部5~20份、冰片5~20份、儿茶5~15份、鹅不食5~20份、苍耳子10~30份、黄柏2~15份、凡士林5~20份和肉豆蔻2~15份。
进一步的,以重量份计,苦参10~15份、百部10~15份、冰片10~15份、儿茶8~10份、鹅不食10~15份、苍耳子15~20份、黄柏5~10份、凡士林10~15份和肉豆蔻5~10份。
进一步的,以重量份计,苦参12份、百部12份、冰片12份、儿茶9份、鹅不食12份、苍耳子17份、黄柏8份、凡士林13份和肉豆蔻7份。
这样设计的目的在于,苦参,《得配本草》:"入手、足太阴经气分。"功能主治:补中,益气,生津。治脾胃虚弱,气血两亏,体倦无力,食少,口渴,久泻,脱肛。①《本经逢原》:"清肺。"②《本草从新》:"补中益气,和脾胃,除烦渴。"③《纲目拾遗》:"治肺虚,益肺气。"④《科学的民间药草》:"补血剂。适用于慢性贫血,萎黄病,白血病,腺病,佝偻病。"⑤《中药材手册》:"治虚劳内伤,肠胃中冷,滑泻久痢,气喘烦渴,发热自汗,妇女血崩、胎产诸病。
百部,止咳化痰。古人多用百部治疗久咳,痰多,因久咳者肺气素虚,百步可根据寒热分别调理止咳化痰。风寒咳嗽则佐以生姜;肺热咳嗽则和蜜。用于肺结核、长期咳嗽、肺痨咳嗽、百日咳、哮喘等症。百部润而不燥,能开泄降气,清肺热而解表,用于皮肤疥癣、湿疹、牛皮癣、遍身黄肿、皮炎、湿疹等症。
冰片,主治:开窍,辟秽,通络,散瘀。治中风,痰厥,惊痫,中恶烦闷,心腹暴痛,癥瘕癖积,跌打损伤,痈疽肿毒。
儿茶,用于跌扑伤痛,外伤出血,吐血衄血,疮疡不敛,湿疹、湿疮,肺热咳嗽。《本草纲目》:清上膈热,化痰生津。涂金疮、一切诸疮,生肌定痛,止血收湿。《本经逢原》:孩儿茶,一名乌爹泥,性涩收敛,止血收湿,为金疮止痛生肌之要药。
鹅不食,性味,辛,温。归经:归肺、肝经。功能主治:通鼻窍,止咳,用于风寒头痛,咳嗽痰多,鼻塞不通,鼻渊流涕。
苍耳子,性味,辛、苦,温;有毒。归经:归肺经。功能主治,苍耳子,散风除湿,通鼻窍。用于风寒头痛,鼻渊流涕,风疹瘙痒,湿痹拘挛。
黄柏,性味:苦,寒。归经:归肾、膀胱经。功能主治:清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,痿{辟},骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。《本草经疏》:"阴阳两虚之人,病兼脾胃薄弱,饮食少进及食不消,或兼泄泻,或恶冷物及好热食;肾虚天明作泄;上热下寒,小便不禁;少腹冷痛,子宫寒;血虚不孕,阳虚发热,瘀血停滞,产后血虚发热,金疮发热;痈疽溃后发热,伤食发热,阴虚小水不利,痘后脾虚小水不利,血虚不得眠,血虚烦躁,脾阴不足作泄等证,法咸忌之。"
凡士林,为白色至微黄色均匀的软裔状物;无臭或几乎无臭;与皮肤接触有滑腻感;具有拉丝性,可以作为其他药粉的载体,不易挥发使药物成分能够持续作用于患处,达到治疗的作用。
肉豆蔻,辛,苦,温,温中涩肠;行气消食。主虚泻;冷痢;脘腹胀痛;食少呕吐;宿食不消,《本草正义》:肉豆蔻,除寒燥湿,解结行气,专理脾胃,颇与草果相近,则辛温之功效本同,惟涩味较甚,并能固及大肠之滑脱,四神丸中有之。温脾即以温肾,是为中下两焦之药,与草果之专主中焦者微别。大明谓温中下气,开胃,解酒毒。甄权谓治宿食痰饮,止小儿吐逆不下乳,腹痛。李珣谓主心腹虫痛。皆专就寒湿一边着想者。若湿热郁滞而为此诸症,则必不可一例论治。故李珣又谓主脾胃虚冷虚泄。濒湖谓暖脾胃、固大肠。要言不烦,最为精切。惟珣又谓治亦白痢,则湿热者多,虚寒者少,不当泛泛言之矣。
各种药材配伍使用,可以达到辨证求因、审因施治、进行整体调节和系统治疗的效果。
可选的,中药还包括辛夷和蒲公英,以重量份计,苦参12份、百部12份、冰片12份、儿茶9份、鹅不食12份、苍耳子17份、黄柏8份、凡士林13份、肉豆蔻7份、辛夷5份和蒲公英5份。
这样设计的目的在于,辛夷能够治疗风寒感冒,鼻塞,鼻渊;蒲公英别名黄花地丁、婆婆丁、华花郎等。菊科多年生草本植物。头状花序,种子上有白色冠毛结成的绒球,花开后随风飘到新的地方孕育新生命。其为菊科植物蒲公英、碱地蒲公英或同属数种植物的干燥全草。苦、甘,寒。主要用于疔疮肿毒,乳痈,瘰疬,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛等。两者配合使用能够达到宣肺,利气,修复溃烂的鼻粘膜,从而配合治疗鼻炎的效果。
本发明还提供了一种治疗鼻炎的中药的制备方法,包括以下步骤:
a.将5~20份苦参、5~20份百部、5~15份儿茶、5~20份鹅不食和10~30份苍耳子干燥、粉碎磨成细粉、过筛,制得组合粉末;
b.将5~20份冰片、2~15份黄柏、5~20份凡士林和2~15份肉豆蔻加水煎煮、过滤、浓缩浸膏,制得膏状物;
c.将组合粉末与膏状物混合均匀制得混合物,混合物再与活化的酵母液混合发酵,制得发酵液;
d.将制得的发酵液中加入乙醇,静置,离心,小分子化,通过干燥,进行提纯,制得治疗鼻炎的中药。
进一步的,步骤a中,干燥温度为60℃,过筛的目数为100目。
进一步的,步骤b中,将四种原料加水煎煮3次,每次煎煮加水体积为原料体积的12倍,每次煎煮2小时,过滤后,在-0.08~-0.09MPa,60℃~70℃的环境下浓缩至相对密度为1.25~1.30浸膏。
进一步的,步骤c中,先将混合物放置于高压蒸锅中隔水灭菌30min,然后取出冷却至室温,再将混合物与活化的酵母液按照1g:0.6~0.8ml配比混合后,在25℃恒温闭光发酵3d。
进一步的,乙醇浓度为65%~80%,乙醇加入的体积与发酵液的体积比为3~5:1,干燥为喷雾干燥。
这样设计的目的在于,通过将药性相近的原料进行处理,使之药效能够相配伍,同时将通过发酵、小分子化、提纯处理可以使之药性温和,不易对患者皮肤造成红肿、起泡等不良反应。
本发明的有益效果至少是以下之一:
1.苦参、百部与冰片配伍使用可以补充患者正气提高免疫力,能够促进自身免疫细胞杀灭病毒。
2.儿茶、鹅不食、苍耳子、黄柏和肉豆蔻,各种药材配伍使用,可以达到辨证求因、审因施治、进行整体调节和系统治疗的效果。
3.凡士林可以作为其他药粉的载体,不易挥发使药物成分能够持续作用于患处,达到治疗的作用。
4.通过将药性相近的原料进行处理,使之药效能够相配伍,同时将通过发酵、小分子化、提纯处理可以使之药性温和,不易对患者皮肤造成红肿、起泡等不良反应。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例对本发明作进一步详细说明。应当理解,此处所描述的具体实施例仅仅用于解释本发明,并不用于限定本发明。
实施例1
基于以下重量份配比制作治疗鼻炎的中药:
先将5份苦参、5份百部、5份儿茶、5份鹅不食、10份苍耳子在60℃环境下干燥、粉碎磨成细粉、使用100目筛网过筛,制得组合粉末;
然后将5份冰片、2份黄柏、5份凡士林、2份肉豆蔻加水煎煮3次,每次煎煮加水体积为原料体积的12倍,每次煎煮2小时,过滤后,在-0.08MPa,60℃的环境下浓缩至相对密度为1.25浸膏制得膏状物;
再将组合粉末与膏状物混合均匀制得混合物,放置于高压蒸锅中隔水灭菌30min,然后取出冷却至室温,再将混合物与活化的酵母液按照1g:0.6ml配比混合后,在25℃恒温闭光发酵3d,制得发酵液;
最后将制得的发酵液中加入乙醇,乙醇浓度为65%,乙醇加入的体积与发酵液的体积比为3:1,静置,离心,小分子化,通过喷雾干燥,进行提纯,制得一种治疗鼻炎的中药。
实施例2
基于以下重量份配比制作治疗鼻炎的中药:
先将20份苦参、20份百部、15份儿茶、20份鹅不食、30份苍耳子在60℃环境下干燥、粉碎磨成细粉、使用100目筛网过筛,制得组合粉末;
然后将20份冰片、15份黄柏、20份凡士林、15份肉豆蔻加水煎煮3次,每次煎煮加水体积为原料体积的12倍,每次煎煮2小时,过滤后,在-0.09MPa,60℃的环境下浓缩至相对密度为1.30浸膏制得膏状物;
再将组合粉末与膏状物混合均匀制得混合物,放置于高压蒸锅中隔水灭菌30min,然后取出冷却至室温,再将混合物与活化的酵母液按照1g:0.8ml配比混合后,在25℃恒温闭光发酵3d,制得发酵液;
最后将制得的发酵液中加入乙醇,乙醇浓度为80%,乙醇加入的体积与发酵液的体积比为5:1,静置,离心,小分子化,通过喷雾干燥,进行提纯,制得一种治疗鼻炎的中药。
实施例3
基于以下重量份配比制作治疗鼻炎的中药:
先将12份苦参、12份百部、9份儿茶、12份鹅不食、17份苍耳子在60℃环境下干燥、粉碎磨成细粉、使用100目筛网过筛,制得组合粉末;
然后将12份冰片、8份黄柏、13份凡士林、7份肉豆蔻加水煎煮3次,每次煎煮加水体积为原料体积的12倍,每次煎煮2小时,过滤后,在-0.09MPa,60℃的环境下浓缩至相对密度为1.28浸膏制得膏状物;
再将组合粉末与膏状物混合均匀制得混合物,放置于高压蒸锅中隔水灭菌30min,然后取出冷却至室温,再将混合物与活化的酵母液按照1g:0.7ml配比混合后,在25℃恒温闭光发酵3d,制得发酵液;
最后将制得的发酵液中加入乙醇,乙醇浓度为70%,乙醇加入的体积与发酵液的体积比为4:1,静置,离心,小分子化,通过喷雾干燥,进行提纯,制得一种治疗鼻炎的中药。
实施例4
在患者自愿的前提下,甄选出212名患者,患者的年龄分布在30周岁至35周岁,罹患鼻炎的年限在3至4年,病理及病状相似,均匀区分为4组,每组男女比例相当,每组53人,将实施例1、实施例2和实施例3制得治疗鼻炎的中药分别标记为A组、B组和C组,且A组与实施例1对应用于第一组患者,B组与实施例2对应用于第二组患者,C组与实施例3对应用于第三组患者,第四组患者按正常剂量服用抗组胺药,其中A组、B组和C组使用中将棉签蘸取黄豆大小本发明中药,涂抹至鼻径内侧两翼处1个小时,每日一次,连续使用,统计4组情况得下表:
其中“治愈”指病情得到好转,且持续追踪20个月鼻炎未复发;“有效”指病情得到好转,但是持续追踪20个月鼻炎存在复发;“无效”指病情未得到好转,患者依旧存在鼻塞、流鼻涕、头痛、头晕等病状,“不良反应”指使用药品后患者皮肤造成红肿、起泡等病状。
本发明通过将9种中药按照一定比例进行组合,再经过相应工序进行制备而得出的治疗鼻炎的中药,对鼻炎的治疗有效率高于现有药剂,其治愈率远高于现有药剂,能够达到治愈鼻炎的效果,其出现不良反应例数远低于现有药剂。同时对比A组、B组和C组数据可得,选用C组制备方法和原料配比制得治疗鼻炎中药,针对鼻炎的治愈率和有效率最高。
9种中药中,百部和黄柏并非直接用于治疗鼻炎,其主要与苦参、儿茶和鹅不食配伍达到大幅提高其治疗效果的目的。同时在制备工艺众,本发明采用了发酵、小分子化、提纯处理可以使之药性温和,大大降低了对患者造成不良反应的几率。
Claims (10)
1.一种治疗鼻炎的中药,其特征在于:所述中药包括苦参、百部、冰片、儿茶、鹅不食、苍耳子、黄柏、凡士林和肉豆蔻。
2.根据权利要求1所述的一种治疗鼻炎的中药,其特征在于:以重量份计,所述苦参5~20份、百部5~20份、冰片5~20份、儿茶5~15份、鹅不食5~20份、苍耳子10~30份、黄柏2~15份、凡士林5~20份和肉豆蔻2~15份。
3.根据权利要求2所述的一种治疗鼻炎的中药,其特征在于:以重量份计,所述苦参10~15份、百部10~15份、冰片10~15份、儿茶8~10份、鹅不食10~15份、苍耳子15~20份、黄柏5~10份、凡士林10~15份和肉豆蔻5~10份。
4.根据权利要求3所述的一种治疗鼻炎的中药,其特征在于:以重量份计,所述苦参12份、百部12份、冰片12份、儿茶9份、鹅不食12份、苍耳子17份、黄柏8份、凡士林13份和肉豆蔻7份。
5.根据权利要求4所述的一种治疗鼻炎的中药,其特征在于:所述中药还包括辛夷和蒲公英,以重量份计,所述苦参12份、百部12份、冰片12份、儿茶9份、鹅不食12份、苍耳子17份、黄柏8份、凡士林13份、肉豆蔻7份、辛夷5份和蒲公英5份。
6.一种治疗鼻炎的中药的制备方法,其特征在于:包括以下步骤:
a.将5~20份苦参、5~20份百部、5~15份儿茶、5~20份鹅不食和10~30份苍耳子干燥、粉碎磨成细粉、过筛,制得组合粉末;
b.将5~20份冰片、2~15份黄柏、5~20份凡士林和2~15份肉豆蔻加水煎煮、过滤、浓缩浸膏,制得膏状物;
c.将组合粉末与膏状物混合均匀制得混合物,混合物再与活化的酵母液混合发酵,制得发酵液;
d.将制得的发酵液中加入乙醇,静置,离心,小分子化,通过干燥,进行提纯,制得一种治疗鼻炎的中药。
7.根据权利要求6所述的一种治疗鼻炎的中药的制备方法,其特征在于:所述步骤a中,干燥温度为60℃,过筛的目数为100目。
8.根据权利要求6所述的一种治疗鼻炎的中药的制备方法,其特征在于:所述步骤b中,将四种原料加水煎煮3次,每次煎煮加水体积为原料体积的12倍,每次煎煮2小时,过滤后,在-0.08~-0.09MPa,60℃~70℃的环境下浓缩至相对密度为1.25~1.30浸膏。
9.根据权利要求6所述的一种治疗鼻炎的中药的制备方法,其特征在于:所述步骤c中,先将混合物放置于高压蒸锅中隔水灭菌30min,然后取出冷却至室温,再将混合物与活化的酵母液按照1g:0.6~0.8ml配比混合后,在25℃恒温闭光发酵3d。
10.根据权利要求6所述的一种治疗鼻炎的中药的制备方法,其特征在于:所述步骤d中,乙醇浓度为65%~80%,乙醇加入的体积与发酵液的体积比为3~5:1,干燥为喷雾干燥。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710713105.5A CN107334991A (zh) | 2017-08-18 | 2017-08-18 | 一种治疗鼻炎的中药及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710713105.5A CN107334991A (zh) | 2017-08-18 | 2017-08-18 | 一种治疗鼻炎的中药及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107334991A true CN107334991A (zh) | 2017-11-10 |
Family
ID=60215356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710713105.5A Pending CN107334991A (zh) | 2017-08-18 | 2017-08-18 | 一种治疗鼻炎的中药及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107334991A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109223898A (zh) * | 2018-12-13 | 2019-01-18 | 胡献军 | 一种鼻炎治疗药膏及其制备方法 |
CN109998008A (zh) * | 2018-09-25 | 2019-07-12 | 浙江杏林堂生物科技有限公司 | 一种佛手百合固体饮料及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444605B (zh) * | 2008-12-19 | 2011-09-14 | 汪延双 | 治疗鼻炎鼻窦炎的外用塞鼻药物及其生产方法 |
CN102579661A (zh) * | 2012-03-05 | 2012-07-18 | 哈尔滨济博生物技术开发有限公司 | 一种治疗鼻炎的外用药物 |
CN105943609A (zh) * | 2016-06-20 | 2016-09-21 | 东莞市乐堂医疗投资有限公司 | 一种治疗鼻炎的中药外用制剂及其制备方法 |
CN106389618A (zh) * | 2016-10-17 | 2017-02-15 | 李大志 | 一种治疗鼻炎、鼻窦炎的中药制剂和使用方法 |
-
2017
- 2017-08-18 CN CN201710713105.5A patent/CN107334991A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444605B (zh) * | 2008-12-19 | 2011-09-14 | 汪延双 | 治疗鼻炎鼻窦炎的外用塞鼻药物及其生产方法 |
CN102579661A (zh) * | 2012-03-05 | 2012-07-18 | 哈尔滨济博生物技术开发有限公司 | 一种治疗鼻炎的外用药物 |
CN105943609A (zh) * | 2016-06-20 | 2016-09-21 | 东莞市乐堂医疗投资有限公司 | 一种治疗鼻炎的中药外用制剂及其制备方法 |
CN106389618A (zh) * | 2016-10-17 | 2017-02-15 | 李大志 | 一种治疗鼻炎、鼻窦炎的中药制剂和使用方法 |
Non-Patent Citations (2)
Title |
---|
丁淑华,等编著: "《中医五官科学》", 30 June 2006, 中国中医药出版社 * |
贾天柱,等编著: "《中药炮制化学》", 31 October 2015, 上海科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109998008A (zh) * | 2018-09-25 | 2019-07-12 | 浙江杏林堂生物科技有限公司 | 一种佛手百合固体饮料及其制备方法 |
CN109223898A (zh) * | 2018-12-13 | 2019-01-18 | 胡献军 | 一种鼻炎治疗药膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109350718A (zh) | 祛湿中药组合物及其制备方法 | |
CN104026672A (zh) | 一种白药子清热解毒汤料及其生产方法 | |
CN107334991A (zh) | 一种治疗鼻炎的中药及制备方法 | |
CN104026676A (zh) | 一种车前草清热解毒汤料及其生产方法 | |
CN104026669A (zh) | 一种败酱草清热解毒汤料及其生产方法 | |
CN103638459B (zh) | 一种用于防治病毒性脑膜炎的中药组合物及其制备方法 | |
CN103989973A (zh) | 一种治疗心源性哮喘的中药组合物 | |
CN103805429A (zh) | 一种蓝莓润肺止咳酒及生产方法 | |
CN104026666A (zh) | 一种车前草清肝明目汤料及其生产方法 | |
CN105902985A (zh) | 一种足浴粉 | |
CN104958757A (zh) | 压疮膏及压疮膏的制备方法 | |
CN104208547B (zh) | 一种治疗脾虚痰聚型梅核气的中药 | |
CN101940760B (zh) | 治疗慢性气管炎的中药 | |
CN105748679A (zh) | 一种治疗猪热毒、痢疾的中药处方 | |
CN105770844A (zh) | 一种治疗胃及十二指肠溃疡的药物及其制备方法 | |
CN105212213A (zh) | 一种罗汉果健脑安神冲剂及生产方法 | |
CN104784567B (zh) | 一种治疗泌尿系感染的药物组合物 | |
CN104258306A (zh) | 一种治疗小儿嗜酸性粒细胞增多症的中药制剂 | |
CN105167029A (zh) | 一种菊花清肝明目汤料及其生产方法 | |
CN103805452A (zh) | 一种山葡萄强心健脑酒及生产方法 | |
CN103966061A (zh) | 一种蓝莓活血化瘀酒及生产方法 | |
CN113616762A (zh) | 一种疏通经络的外用中草药止痛喷剂及其制备方法 | |
CN107496794A (zh) | 一种治疗支气管哮喘的丸剂药物及其制备方法 | |
CN105212212A (zh) | 一种松茸消炎止咳冲剂及生产方法 | |
CN105687733A (zh) | 一种治疗阴虚火旺型感染性心内膜炎的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171110 |